Overview

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome

Phase:

Phase 3

Details

Lead Sponsor:

Kissei Pharmaceutical Co., Ltd.

Treatments:

Ophthalmic Solutions